Work

Additional file 3: Table S3. of Ridaforolimus (MK-8669) synergizes with Dalotuzumab (MK-0646) in hormone-sensitive breast cancer

Year: 2016

Type: dataset

Abstract: Statistical analysis of IRB expression for samples depicted in Fig.Â 1. (XLSX 44Â kb)

Source: Figshare

DOI: 10.6084/m9.figshare.c.3602345_d3

Authors: Becker, Marc, Xiaonan Hou, Piyawan Tienchaianada, Haines, Brian, Harrington, Sean, S. Weroha, Sriram Sathyanarayanan, Haluska, Paul

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W4394147079

Cites:

Cited by:

Related to: 10